National Health (Continued Dispensing – Emergency Measures) Amendment Determination 2020 (No.6) (PB 70 of 2020) (Cth)

PB 70 of 2020

National Health (Continued Dispensing – Emergency Measures) Amendment Determination 2020 (No. 6)

I, NIKOLAI TSYGANOV, Assistant Secretary (Acting), Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health make the following determination.

Dated               30 july             2020

Nikolai Tsyganov

Assistant Secretary (Acting)

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health

Contents

1...... Name

2...... Commencement............................................................................................................................... 1

3...... Authority......................................................................................................................................... 1

4 ..... Schedule.......................................................................................................................................... 1

Schedule 1—Amendments   2

National Health (Continued Dispensing - Emergency Measures) Determination 2020         2

1  Name

(1) This instrument is the National Health (Continued Dispensing – Emergency Measures) Amendment Determination 2020 (No.6).

(2) This instrument may also be cited as PB 70 of 2020.

2  Commencement

(1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

Commencement information
Column 1	Column 2	Column 3
Provisions	Commencement	Date/Details
1.  The whole of this instrument	1 August 2020.

Note:          This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

(2)  Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3  Authority

This instrument is made under subsection 89A(3) of the National Health Act 1953.

4  Schedules

Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

Schedule 1—Amendments

National Health (Continued Dispensing – Emergency Measures) Determination 2020

1. Schedule 1, after entry for Entacapone

insert:

Entrectinib Capsule 200 mg Oral

1. Schedule 1, after entry for Loperamide

insert:

Lorlatinib	Tablet 25 mg	Oral
Tablet 100 mg	Oral

1. Schedule 1, entry for Metformin

substitute:

Metformin	Tablet containing metformin hydrochloride 500 mg	Oral
Tablet containing metformin hydrochloride 850 mg	Oral
Tablet containing metformin hydrochloride 1 g	Oral
Tablet (extended release) containing metformin hydrochloride 500 mg	Oral
Tablet (extended release) containing metformin hydrochloride 1 g	Oral
Tablet (prolonged release) containing metformin hydrochloride 500 mg	Oral

1. Schedule 1, entry for Salbutamol

substitute:

Salbutamol	Nebuliser solution 2.5 mg (as sulfate) in 2.5 mL single dose units, 20	Inhalation
Nebuliser solution 2.5 mg (as sulfate) in 2.5 mL single dose units, 30	Inhalation
Nebuliser solution 5 mg (as sulfate) in 2.5 mL single dose units, 20	Inhalation
Nebuliser solution 5 mg (as sulfate) in 2.5 mL single dose units, 30	Inhalation
Oral solution 2 mg (as sulfate) per 5 mL, 150 mL	Oral
Pressurised inhalation in breath actuated device 100 micrograms (as sulfate) per dose, 200 doses (CFC‑free formulation)	Inhalation by mouth
Pressurised inhalation 100 micrograms (as sulfate) per dose, 200 doses (CFC‑free formulation)	Inhalation by mouth
Pressurised inhalation 100 micrograms (as sulfate) per dose with dose counter, 200 doses (CFC-free formulation)	Inhalation by mouth

1. Schedule 1, after entry for Sterculia with frangula bark

insert:

Stiripentol	Capsule 250 mg	Oral
Capsule 500 mg	Oral
Powder for oral suspension 250 mg	Oral
Powder for oral suspension 500 mg	Oral